Methylene blue arterial perfusion increases lymph node detection in rectal cancer resection patients
This retrospective cohort study evaluated 120 patients undergoing radical rectal cancer resection at a hospital in Bengbu City. The experimental group received methylene blue arterial perfusion via the inferior mesenteric artery with heparinization of the surgical specimen post-extraction, while the control group received no special treatment after specimen removal. The primary outcome was total postoperative lymph node detection rates, with secondary outcomes including positive lymph node detection rates and average time per lymph node examined.
Main results showed the experimental group had significantly higher total lymph node detection compared to the control group (27.783 ± 9.243 vs. 15.317 ± 7.480, P < 0.05). The total number of negative lymph nodes detected was also higher in the experimental group, and the average time per lymph node examined was reduced. Safety and tolerability data were not reported in the study.
Key limitations include the retrospective design, single-center setting, and lack of reported safety data. The study population was specific to patients undergoing radical rectal cancer resection at one hospital. Practice relevance suggests this approach may help ensure accurate pathological staging and provide more precise evidence for postoperative prognosis assessment and treatment planning in rectal cancer, but these findings should be interpreted cautiously pending further research.